Longevity Supplement
Effectiveness limited by preliminary human data: only 6 RCTs for NMN showing NAD+ increase but no longevity outcomes (e.g., 2024 meta-analysis on lipids/glucose, no benefits; Examine.com D-grade). 400mg NMN aligns with trials (PMID:38191197, 250mg), but 100mg trans-resv below effective ranges for cardio (B-grade, 27 studies/1,648 participants). Safety strong with no issues in short-term trials (up to 12wks). Quality decent via COA/third-party purity tests, but lacks gold-standard certs like NSF.
Cymbiotika NMN + Trans-Resveratrol provides 400mg NMN at clinically tested doses boosting NAD+ (6 RCTs), paired with low-dose 100mg trans-resv, but lacks strong human longevity evidence (Examine D/B grades). Safe with COA, but no elite certifications and pricey vs. averages. Average for exploratory longevity use.